Metabolic Changes in Children that Received Chemotherapy

Area of Science:

• Pediatric Oncology
• Metabolic Health
• Epidemiology

Background:

• Cancer treatments can cause short- and long-term health effects.
• Young cancer survivors are increasingly diagnosed with metabolic syndrome (MS), obesity, or overweight.
• Chemotherapy's impact on metabolic health in pediatric patients requires further investigation.

Purpose of the Study:

• To determine the prevalence of unhealthy weight status in pediatric cancer patients.
• To identify risk factors for metabolic syndrome (MS) associated with chemotherapy.
• To analyze key metabolic and anthropometric parameters in young cancer survivors.

Main Methods:

• Study included 52 pediatric cancer patients.
• Analyzed body mass index (BMI), waist circumference (WC), triglycerides, cholesterol, glycosylated hemoglobin, and FINDRISC test scores.
• Parameters were assessed based on age- and sex-specific percentiles.

Main Results:

• Significant modifications observed in weight, BMI, and WC.
• Elevated triglycerides and cholesterol levels were noted.
• Variance analysis confirmed a statistical correlation between WC, triglycerides, and cholesterol.

Conclusions:

• Pediatric cancer survivors exhibit altered weight status and metabolic markers potentially linked to MS development.
• A statistically significant correlation exists between WC, triglycerides, and cholesterol.
• Regular follow-up for metabolic syndrome (MS) is essential for pediatric cancer survivors.